- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.08. | Basel Medical Group beruft Darren Tan zum neuen Chief Commercial Officer | 2 | Investing.com Deutsch | ||
| 21.08. | Basel Medical Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 13.08. | Basel Medical Group: Chief Partnership Officer tritt zurück | 4 | Investing.com Deutsch | ||
| BASEL MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 13.08. | Basel Medical Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 18.07. | Basel Medical Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 17.07. | Basel Medical Group Puts the acquisition of BTC digital asset on hold | 8 | Seeking Alpha | ||
| 17.07. | Basel Medical Group Ltd: Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset | 552 | GlobeNewswire (Europe) | Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the "Company"), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough... ► Artikel lesen | |
| 09.07. | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | 910 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| 26.06. | Basel Medical Group Ltd - 6-K, Report of foreign issuer | 8 | SEC Filings | ||
| 26.06. | Basel Medical Group Ltd: Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising | 8 | GlobeNewswire (USA) | ||
| 18.06. | Basel Medical Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 03.06. | Basel Medical Group Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 31.05. | Why Basel Medical Group Ltd (BMGL) Surged Last Week | 28 | Insider Monkey | ||
| 30.05. | Pre-market Movers: Bolt Projects, Basel Medical Group, Red Robin Gourmet Burgers, LZ Technology, Medicus Pharma | 1.130 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 06.55 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 114%... ► Artikel lesen | |
| 29.05. | Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility | 583 | GlobeNewswire (Europe) | Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the "Company"), today reaffirmed the strength of its underlying financial performance and strategic outlook, despite... ► Artikel lesen | |
| 16.05. | Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move | 990 | GlobeNewswire (Europe) | Singapore, May 16, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the "Company"), today announced that it has begun exclusive negotiations for a US$1 billion BTC acquisition that... ► Artikel lesen | |
| 30.04. | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | 286 | GlobeNewswire (Europe) | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
| 11.04. | Basel Medical Group Ltd: Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | 386 | GlobeNewswire (Europe) | Singapore, April 11, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire... ► Artikel lesen | |
| 03.03. | Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering | 328 | GlobeNewswire (Europe) | Singapore, March 03, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the "Company") (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services... ► Artikel lesen | |
| 25.02. | Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering | 243 | GlobeNewswire (Europe) | Singapore, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the "Company") (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 277,80 | 0,00 % | UNITEDHEALTH GROUP INC: Jetzt wird's ernst am Markt! | ||
| HIMS & HERS HEALTH | 30,140 | +0,03 % | Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model | ||
| SIEMENS HEALTHINEERS | 41,770 | +1,16 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Siemens Healthineers, Deutsche Bank und Suss Microtec | © Foto: Daniel Karmann/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 10:00... ► Artikel lesen | |
| FRESENIUS | 46,940 | +0,34 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
17.11.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,540 | +2,32 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,360 | +1,98 % | Carl Zeiss Meditec-Aktie mit Aufwärtssignalen - Experten halten große Kursgewinne für möglich! | ||
| GERRESHEIMER | 23,560 | 0,00 % | EQS-News: Gerresheimer AG: Science Based Targets Initiative bestätigt CO2e Reduktionsziele | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer: Science Based Targets Initiative bestätigt CO2e Reduktionsziele
18.11.2025 / 10:02 CET/CEST
Für... ► Artikel lesen | |
| BETA BIONICS | 31,420 | +10,32 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,830 | +6,96 % | Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 4,710 | +53,42 % | Mobile-health Network Solutions Signs MOU to Secure Two Malaysian AI Data Center Projects; Facilities Intended to Power Expansion of Company's AI Digital Health Platform | Singapore, Singapore--(Newsfile Corp. - November 21, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced the signing... ► Artikel lesen | |
| OTTOBOCK | 70,85 | -2,95 % | ANALYSE-FLASH: Jefferies startet Ottobock mit 'Buy' - Ziel 84 Euro | NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Bewertung von Ottobock beim Kursziel von 84 Euro mit "Buy" aufgenommen. Der Rollstuhlspezialist spiele eine globale Führungsrolle im Bereich... ► Artikel lesen | |
| GENEDX | 146,55 | +9,29 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| BRIGHTSPRING HEALTH SERVICES | 34,620 | +5,71 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 25,850 | +4,11 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| ECKERT & ZIEGLER | 15,470 | +0,19 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Eckert & Ziegler auf "Buy" mit einem Kursziel von 24 Euro belassen. Der Strahlen- und Medizintechnikkonzern habe durchwachsene Zahlen vorgelegt... ► Artikel lesen |
BASEL MEDICAL GROUP LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,030 (-2,44 %) liegt der Kurs bei 1,200 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BASEL MEDICAL GROUP LTD finden Sie auf Wallstreet Online.